Integra LifeSciences
IART
207 hedge funds and large institutions have $1.04B invested in Integra LifeSciences in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 65 increasing their positions, 77 reducing their positions, and 33 closing their positions.
16% more capital invested
Capital invested by funds: $897M → $1.04B (+$147M)
0% less funds holding
Funds holding: 208 → 207 (-1)
0.57% less ownership
Funds ownership: 94.06% → 93.5% (-0.57%)
3% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 33
16% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 77
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
+$10.3M |
| 2 |
Neuberger Berman Group
New York
|
+$9.27M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$8.2M |
| 4 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$4.77M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$10.1M |
| 2 |
Millennium Management
New York
|
-$8.38M |
| 3 |
Jane Street
New York
|
-$4.09M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.7M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$3.55M |
IART Hedge Fund Activity: Q3 2025 in Review
207 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2025, worth a combined $1.04B — up 16% from $897M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of IART and 32 opened new positions — a net loss of 1 holder — while 77 trimmed existing stakes and 65 added.
The largest buyer was Kent Lake PR, opening a new position worth an estimated $10.3M. The largest seller was Assenagon Asset Management, cutting an estimated $10.1M.
- 207 institutional investors held Integra LifeSciences (IART) as of Q3 2025, down from 208 in Q2 2025.
- Funds reported $1.04B of Integra LifeSciences stock for Q3 2025, up 16% quarter-over-quarter.
- 32 funds opened new Integra LifeSciences positions in Q3 2025 and 33 closed out, a net change of -1 holder.
- The largest Integra LifeSciences buyer in Q3 2025 was Kent Lake PR, an estimated $10.3M added.
- The largest Integra LifeSciences seller in Q3 2025 was Assenagon Asset Management, an estimated $10.1M sold.
Based on aggregated 13F filings for Q3 2025.